David Schreiber

Title: David Schreiber: Innovator in Astaxanthin Production

Introduction

David Schreiber is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of astaxanthin, a valuable pigment with various applications.

Latest Patents

David Schreiber holds 3 patents related to his innovative processes. His latest patents include:

1. **Processes for in vivo production of astaxanthin and Phaffia rhodozyma yeast of enhanced astaxanthin content** - This patent describes an economical process for enhancing the astaxanthin content of cultures of microorganisms. The process involves culturing a microorganism in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating the surviving pigment-enhanced microorganisms, and harvesting the yeast.

2. **Processes for in vivo production of astaxanthin and Phaffia rhodozyma** - This patent outlines a similar economical process for the in vivo production of astaxanthin, focusing on enhancing the pigment content of cultures of the genus Phaffia.

Career Highlights

David Schreiber is currently associated with Igene Biotechnology, Inc., where he continues to advance his research and development efforts in biotechnology. His work has positioned him as a key player in the field of astaxanthin production.

Collaborations

David has collaborated with notable colleagues, including Eric Arthur Johnson and Kwok P Ho, contributing to the advancement of their shared goals in biotechnology.

Conclusion

David Schreiber's innovative work in the production of astaxanthin showcases his commitment to advancing biotechnology. His patents reflect his expertise and dedication to enhancing the efficiency of microbial processes.